- Dose range
- 10-25 mg/day
- Route
- Oral, once daily
- Indication(s)
- Oral ghrelin mimetic; GH/IGF-1 elevation
Titration schedule
| Step | Dose | Duration | Notes |
|---|---|---|---|
| - | 10-25 mg | Once daily, oral | Ghrelin mimetic; some patients cycle off due to appetite |
Important notes
- This research compound dosing chart is intended as a reference for clinicians and patients reviewing protocols, not a substitute for individualized prescriber guidance.
- Research compound; not FDA-approved for any indication. Off-label or experimental use only.
- Compounded versions, where applicable, must be prepared by a licensed 503A or 503B compounding pharmacy. The April 14, 2026 FDA action restricted salt-form active ingredients.
References
- MK-677 (ibutamoren) prescribing information / clinical literature.
- FDA Section 503A Interim Bulk Drug Substances List, updated April 14, 2026.
- USP <797>: Pharmaceutical Compounding — Sterile Preparations.